Back to discover
Disease

Urinary Incontinence, Urge

Late-stage therapeutic developmentEmerging research
1
Publications
11
Clinical trials
2026
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 2 clinical trials expected to report results, the earliest in Q3 2026.
  • Active recent publication activity, including 1 notable finding.

Therapeutic landscape

Therapies with a regulatory footing for this condition, alongside the wider set of agents co-studied with it in the literature.

Approved & established therapies

Approval — Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency… (2004)

Oxybutyninapproved

Approval — Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency… (2004)

Clinical trials

8 sponsors · 1 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
11
All trials
2
Active
7
Late-stage
6
Completed
Late-stage studies
Recently completed

Regulatory timeline

Drug regulatory events matched to this condition by indication — EMA.

First approvals
2004emaApprovalDarifenacin hydrobromide· Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with overactive bladder syndrome. source ↗
2004emaApprovalOxybutynin· Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder. source ↗

European Medicines Agency (CC BY 4.0). Events are matched to this condition by drug indication text — approvals/updates for drugs indicated for it, not disease-specific acts.

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes6
  • Electric Stimulation Therapy1
  • Urethra1
  • Urinary Incontinence1
  • Urinary Incontinence, Stress1
  • Urinary Incontinence, Urge1
  • Wireless Technology1
Leading journals1
  • Nature communications1
Leading researchers8
  • Gao Q1
  • Kang N1
  • Lee CHT1
  • Liu M1
  • Ma C1
  • Shao L1
  • Shao Y1
  • Sitti M1
Affiliations (unnormalised)6
  • Global College1
  • Lee Kong Chian School of Medicine1
  • Max Planck Institute for Intelligent Systems1
  • Ruijin Hospital1
  • School of Electrical and Electronic Engineering1
  • School of Electrical Engineering1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Involuntary discharge of URINE that is associated with an abrupt and strong desire to void. It is usually related to the involuntary contractions of the detrusor muscle of the bladder (detrusor hyperreflexia or detrusor instability).

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.